Geriatric Medicine: Dr. B. Goldlist Michael Bloom and Diana Tamir, Chapter Editors Harriette Van Spall, Associate Editor
Geriatric Medicine: Dr. B. Goldlist Michael Bloom and Diana Tamir, Chapter Editors Harriette Van Spall, Associate Editor
Geriatric Medicine: Dr. B. Goldlist Michael Bloom and Diana Tamir, Chapter Editors Harriette Van Spall, Associate Editor
Dr. B. Goldlist
Michael Bloom and Diana Tamir, chapter editors
Harriette Van Spall, associate editor
DEMOGRAPHICS . . . . . . . . . . . . . . . . . . . . . . . . . . 2
COMMON MEDICAL PROBLEMS . . . . . . . . . . . 6
Age Profile OF THE ELDERLY
Gender Falls
Marital Status Immobility
Living Arrangements Urinary Incontinence
Health Status Delirium, Depression and Dementia
Causes of Mortality and Morbidity Among the Elderly
Elder Abuse
Failure to Cope
AGING CHANGES IN BODY SYSTEMS . . . . . . . 3 Malnutrition
In General Hazards of Hospitalization
Physiologic and Pathologic Changes Polypharmacy
GENDER
❏ ratio of elderly females to males in Canada is 1.4:1
❏ this ratio increases to 2:1 for those age 85+
MARITAL STATUS
❏ widows outnumber widowers 5:1
❏ males over 65 are twice as likely to be married compared to females of the same age group
LIVING ARRANGEMENTS
❏ about 5% of the elderly population live in long-term care (LTC) institutions
❏ 1% of persons aged 65-74 live in LTC institutions
❏ 20% of persons aged 85 or older live in LTC institutions
HEALTH STATUS
❏ 64% of seniors rate their health as good, very good or excellent
❏ 92% of seniors say that they are “pretty happy” or “very happy”
❏ 51% of seniors report daily or frequent exercise
❏ 99% of seniors would have sex if a partner was available
Cardiovascular (CVS) Increased: systolic and diastolic BP Increased: atherosclerosis, CAD, MI, CHF,
Decreased: HR, SV, CO, cardiac myocyte size hypertension, arrhythmias
and number, blood vessel elasticity
Gastrointestinal (GI) Increased: intestinal villous atrophy Increased: GI cancer, diverticulitis, constipation,
Decreased: number of teeth, esophageal fecal incontinence, hemorrhoids, intestinal
peristalsis, gastric acid intestinal secretion, obstruction
protein synthesis and drug metabolism
in liver
Integumentary Increased: atrophy of sebaceous and sweat Increased: lentigo, cherry hemangiomas, pruritus,
glands seborrheic keratosis, herpes zoster, decubitus
Decreased: epidermal and dermal thickness, ulcers, skin cancer
dermal vascularity, melanocytes, collagen
synthesis
Musculoskeletal (MSK) Increased: calcium loss from bone Increased: arthritis, bursitis, osteoporosis,
Decreased: muscle mass, cartilage muscle cramps, polymyalgia rheumatica
Reproductive Decreased: androgen and estrogen, Increased: breast and endometrial cancer,
sperm count, vaginal secretions, size of atrophic vaginitis, impotence
uterus, ovaries and breasts
Respiratory Increased: rigidity of tracheal and bronchial Increased: COPD, pneumonia, pulmonary
cartilage embolism
Decreased: lung and chest wall elasticity,
ciliary activity, surface area for gas exchange
Renal and Urologic (GU) Increased: proteinuria, urinary frequency Increased: urinary incontinence, nocturia, BPH,
Decreased: renal mass, GFR, prostate cancer, pyelonephritis, nephrolithiasis,
bladder capacity cystocele, rectocele
Special Senses Increased: inclusion bodies in vitreous Increased: presbyopia, blindness, glaucoma,
(floaters) cataracts, macular degeneration, presbycusis,
Decreased: lacrimal gland secretions, lens tinnitus, deafness, vertigo, oral dryness
transparency, dark adaptation, number of
cochlear neurons, sense of taste and smell
DRIVING COMPETENCY
REPORTING
❏ inform patient that they are unfit to drive ––> report to Registrar of Motor Vehicles
––> decision made by the Motor Vehicle Licensing Authority ––> appeal
❏ objective comprehensive testing of driving ability at an Ontario Driver Testing Centre ($250-$500);
not covered by OHIP but medical expense for income tax purposes
CONDITIONS THAT MAY IMPAIR DRIVING
Visual Impairment
❏ reduced night vision, cataracts, visual processing impairment
❏ visual processing involves the combination of visual sensory function, visual processing speed
and visual attention skills
❏ recommended corrected visual acuity not less than (20/50 = 6/15) with both eyes examined together
as well as an adequate continuous field of vision ––> determined by ophthalmologist/optometrist
Hearing Loss
❏ use car mirror to compensate
❏ caution with hearing aids that can amplify ambient vehicle noise and block out other sounds
❏ patients with vestibular diseases should not drive
Cerebrovascular Conditions
❏ single syncopal episode not yet diagnosised (NYD) - no driving x 1 month except vasovagal syncope
❏ transient ischemic attack (TIA) - no driving until investigated and management
❏ completed stroke - no driving x 1 month, resume if minimal residual effects
but require regular monitoring +/– comprehensive testing
❏ vascular dementia - changed alertness, decision-making ability or personality
Mental Deterioration
❏ MMSE < 24: no driving until complete neurologic assessment
❏ MMSE > 24 + poor judgment, abstract thinking, poor insight: evaluate for driving ability
Musculoskeletal (MSK)
❏ reduced coordination, muscle strength and limited ROM
Cardiovascular (CVS)
❏ undergo cardiac reassessment every two years
❏ NYHA IV (symptoms at rest), >/= 70% narrowing ––> unfit to drive
❏ coronary angioplasty: no driving x 48 hours
❏ acute MI, unstable angina, CABG: no driving x 1 month
❏ stable angina pectoris, suspected asymptomatic CAD, HTN ––> ok to drive
Drugs and Alcohol
❏ analgesics (codeine-containing, narcotics); ophthalmic preparations; antidepressants (TCA); sedatives,
anxiolytics (barbiturates, BZD); antiemetics; skeletal muscle relaxants; antihistamines; antipsychotics etc.
Diabetes Mellitus
❏ if type 2 and compliant ––> ok to drive
❏ if type 1 and compliant and no alcohol/drug abuse or severe hypoglycemic episodes in last 6 months
––> ok to drive
❏ if type 1 and noncompliant or unstable metabolic control ––> no driving x 6 months
Postoperative
❏ conscious sedation, out patient ––> no driving x 24 hours
❏ general anesthesia, out patient ––> no driving at least several days
History
❏ location and activity at time of or near fall (e.g. coughing, urinating, straining), witnesses
❏ associated symptoms: dizziness/light headedness, palpitations, dyspnea,
chest pain, weakness, confusion, loss of consciousness, preceding aura,
incontinence, GI symptoms (bleeding, diarrhea, vomiting)
❏ injuries resulting from falls, including head injury
❏ previous falls, weight loss (malnutrition)
❏ past medical history (heart disease, diabetes, seizure disorder), medications, alcohol/drug use
❏ assessment of home environment – 50% of falls attributed to extrinsic factors
❏ functional status (ADLs)
Physical Examination
❏ complete physical exam with emphasis on
• Vitals: orthostatic changes in heart rate and blood pressure, weight
• Cardiac: jugular venous pressure (JVP), arrhythmias, murmurs, carotid bruits
• Neurologic: level of consciousness, vision, hearing, cranial nerves, muscle power and symmetry,
deep tendon reflexes, sensation, gait and balance, walking, turning, getting in/out of a chair,
Romberg test and sternal push, cognitive screen (if appropriate)
• Abdominal exam including digital rectal exam (DRE)
• Musculoskeletal: assess for injury secondary to fall, degenerative joint disease,
podiatric problems, poorly fitting shoes
Investigations
❏ directed by history and physical exam
❏ common tests
• CBC, lytes, BUN, creatinine, blood glucose, calcium
• TSH, vitamin B12, ESR
• Urinalysis
• cardiac enzymes, ECG
• stool for occult blood
• CT head
Management
❏ most falls in the elderly have multiple causes, thus requiring multidisciplinary assessment
and multiple therapeutic modalities
❏ social work, O.T. (occupational therapy) and P.T. (physiotherapy) referrals may be required
❏ treat underlying cause(s) and any known complications
❏ modify risk factors: reassess medications, need for mobility aids, environmental factors
❏ educate patient and family members about: nutrition, exercises to improve balance and gait
IMMOBILITY
❏ complications associated with immobility
• deep vein thrombus (DVT), pulmonary embolus, pneumonia
• pressure ulcers
• muscle deconditioning and atrophy, contractures
• loss of coordinated balance and righting reflexes
• dehydration, malnutrition
• constipation, fecal impaction, urinary incontinence
• depression, delirium, loss of confidence
Management
❏ prevention: reposition patient periodically, inspect the skin frequently, active and
passive range of motion (ROM) exercises
❏ treat the underlying cause
❏ environmental factors: handrails, lower the bed, chairs at proper height with arms and skid guards,
assistive devices
❏ to maintain and improve function and independence
❏ a multidisciplinary team sees patients either at home or on site
URINARY INCONTINENCE
❏ estimated prevalence 30% of community-dwelling and 75% of institutionalized seniors
❏ frequently accepted, under-reported and under-treated, can lead to isolation
❏ many causes of incontinence are treatable (see Urology Chapter)
❏ mnemonic: DRIP
• D: Delirium/ Diabetes/ Drugs (long-acting sedatives, anticholinergics, diuretics)
• R: Restricted mobility/ Retention (neurogenic detrusor impairment)
• I: Infections (UTIs)/ Impaction of stool
• P: Psychological/ Post-menopausal effects (prolapse)/ Prostate
Physical Examination
❏ calculate body mass index (BMI)
❏ complete examination of all organ systems
Investigations
❏ conduct appropriate work-up to confirm or rule out any of the above medical etiologies
Management
❏ directly treat medical causes
❏ improve body composition by exercise and appropriate food intake
❏ food supplement or external feeding
❏ appetite stimulants and flavour enhancers
❏ physiotherapy, occupational therapy, and aids for functional deficits
❏ counselling, social services (e.g. Meals-on-Wheels), and nursing homes
MALNUTRITION
❏ be concerned with involuntary weight loss of 10% in last 6 months
Risk Factors
❏ sensory decline
❏ poor oral hygiene
❏ disease
❏ medications: polypharmacy, drug-nutrient interactions
❏ social isolation
❏ poverty
❏ substance abuse (EtOH)
Management
❏ monitor height and weight
❏ reassess medications
❏ community services: Meals-on-Wheels, home care, congregate dining
❏ dietitian, social work, occupational therapy
HAZARDS OF HOSPITALIZATION
❏ end result of hospitalization of many elderly patients is nursing home placement
Bed Rest Reduced plasma volume Syncope, dizziness, falls and fracture
Accelerated bone loss Increased fracture risk
Immobilization Pressure sores, infection
Being moved up in bed High shearing forces on fragile skin
Isolation Decreased sensory input Delirium (or false labelling, leading to physical or chemical restraints)
❏ recommendations
• encourage ambulation (low beds without rails)
• reality orientation (clocks, calendars)
• increased sensory stimulation (proper lighting, eyeglasses and hearing aids)
• team management, early discharge planning
POLYPHARMACY
❏ greater burden of chronic illnesses leads to more drug utilization
❏ Adverse Drug Reactions (ADRs)
• the elderly hospitalized are given an average of 10 drugs over admission
• important age-associated complications
• upper GI bleeding secondary to NSAIDs
• hip fracture after falling secondary to psychotropic drugs
• 90% of ADRs from the following: ASA, other analgesics, digoxin, anticoagulants, diuretics,
antimicrobials, steroids, antineoplastics, hypoglycemics
❏ drug interactions
• drug-drug, drug-disease, drug-nutrient risk factors
• multiple drugs: adverse reaction rate is 5% for fewer than 6 drugs but > 40% with over 15 drugs
• changes in pharmacokinetics and pharmacodynamics
• especially watch for drugs that act on or are acted upon by P450 enzymes
❏ non-compliance
• risk is not as age-related as it is drug-related (number, dosing frequency)
• compliance with one drug up to 80% but only 25% with four drugs
• high risk because of multiple:
• physicians
• drugs and doses
• diseases (especially congestive heart failure, hypertension, diabetes mellitus, renal disease)
• important consequences
• disease relapse
• adverse effects
• increased hospitalizations and medical costs
• bubble packs or dosette systems can improve proper drug use
Optimal Pharmacotherapy
❏ be informed of
• presenting symptoms
• detailed and updated medication history and allergies
• patient’s financial situation/drug benefit coverage
• patient’s views on taking medication
• history of dysphagia
❏ medication information needed
• clinical pharmacology and side effects of the drug
❏ other principles
• educate the patient and the caregiver about the medication
• have a simple treatment regimen
• prescribe liquid formulations when necessary
• review medications regularly (discontinue if unnecessary)
• new symptoms and illnesses may be caused by a drug
❏ NB: not only are the elderly sometimes given too many drugs, they are also often undertreated
(e.g. beta blockers, ASA, thrombolytics, coumadin)
GERIATRIC PHARMACOLOGY
❏ see Clinical Pharmacology Chapter
❏ physiologic changes associated with aging affect pharmacodynamics and pharmacokinetics
PHARMACOKINETICS
Absorption
❏ unaltered in patients with an intact gastric mucosa
Distribution
❏ decreased body water content
• increased serum concentration + longer activity of water soluble drugs
❏ increased body fat
• longer pharmacological activity of highly lipid soluble drugs
❏ decreased serum albumin
• more free drug available with highly protein bound drugs
❏ increased α1glycoprotein (an acute phase reactant)
• enhanced binding of basic drugs (lidocaine)
Metabolism
❏ function of the microsomal mixed-function oxidative system declines with age,
resulting in decreased metabolism of drugs
❏ conjugative processes do not appear to be altered
❏ decreased hepatic size and blood flow may reduce drug metabolism even if LFTs are normal
Elimination
❏ beginning in the fourth decade of life, there is a 6-10% reduction in GFR and in
renal blood flow (RBF) every 10 years
❏ a decline in creatinine due to a decline in muscle mass may mask the reduction in GFR
❏ reduced tubular excretion
❏ hypertension is common and can reduce renal function
❏ drugs eliminated primarily by renal excretion should be dosed differently:
for every X% clearance reduction, dose often decreased by X% and interval increased by X%
❏ common drugs eliminated primarily by the kidneys
• digoxin, beta-blockers, ACE inhibitors
• aminoglycoside antibiotics, lithium
• NSAIDs, H2-blockers
PHARMACODYNAMICS
❏ increased tissue sensitivity to drugs acting on the CNS (such as sedative hypnotics and oralgesics),
anticholinergics, and warfarin
❏ decreased beta-receptor sensitivity to agonists and antagonists
Meperidine (Demerol) is not included for the elderly because of its unpredictable length of action, active metabolites,
high anticholinergic activity. Causes more delirium than other narcotics. It is still ordered despite being contraindicated.
BEREAVEMENT
❏ physician should participate in bereavement activities – telephone call or letter to family
❏ family should be made aware of bereavement programs available to them
REFERENCES
Ann Intern Med. 1997. 30(4): 481.
Determining Medical Fitness to Drive: A Guide for Physicians. 6th ed. 2000. CMA. Ottawa.
Hazzard, William R. Principles of Geriatric Medicine and Gerontology. 1994. McGraw-Hill Inc. Toronto.
Verdery, Roy B. Failure to Thrive in Old Age: Follow-up on a Workshop. Journal of Gerontology. 1997. Vol. 52A, No. 6. M333-M336.